Prevention and control of Mycoplasma contamination in bioprocessing
Sponsored by: Parker Bioscience Filtration
- Mycoplasma Contamination
Date: 15 January
Time: 3PM London/10AM New York
Implementing a Holistic Approach to the Prevention of Mycoplasma Contaminations
The Mycoplasma contamination of a facility or process equipment is notoriously difficult to resolve. In fact, large sums are spent to prove that any material (for example a cell line or cell culture media) is Mycoplasma free before releasing it from quarantine. Despite that effort, contamination does occur and when it does the consequences can be very serious for the manufacturer. These can include lost batches, unplanned down time, engineering works and enhanced checks on products. All this impacts the supply of pharmaceutical products, which in turn has a potential negative impact on human health, not to mention a company’s public profile and its share price. Imagine the twitter storm that could blow up around the lack of a medicine or vaccine!
During this webinar, we will look at sources of Mycoplasma contamination and the risks they pose. We will review how these risks can be mitigated and look at industry best practice.
We will discuss the advantages of single-use technology in mitigating the risk of Mycoplasma contamination, before presenting a case study on the filtration of cell culture media. We will then go on to discuss how the automation of that step can optimize filtration performance.
Register now for this webinar to learn how to prevent contamination events in your bioprocess through the implementation of practical control strategies.
Global Market Development Manager
Guy Matthews is the Market Development Manager for Parker Bioscience Filtration. Guy has worked in the biotech industry for over 25 years starting out as a microbiologist at a well-known CMO in the UK before moving in to more commercial roles. At Parker Guy’s role is to lead a team of Product Managers and Marcoms experts in Europe and North America to develop and promote solutions for the manufacture of pharmaceutical products leveraging Parker’s position as the global leader in automation and control technology.
Dr Carolyn Heslop,
Technical Support Group Team Leader
Carolyn Heslop is the Technical Support Group Team Leader for Parker Bioscience Filtration. Carolyn is a Scientist with a BSc (Hons) in Chemistry, a PhD in Analytical Chemistry, and more than 20 years’ experience working in Pharma and Biopharma industries in technical and scientific roles. At Parker, Carolyn’s role is to support and develop filtration solutions. Working with customers, providing dedicated support services to ensure product quality, and improve process control and efficiency.
Key Learning Objectives
- Understand the sources of and the potential threat of Mycoplasma contaminations
- Understand the mitigation strategies that can be deployed
- Understand the benefit of single-use automation to optimize performance and mitigate risk
- Understand how to apply these technologies via a case study
- Purification Scientists
- Downstream Process Development
- Upstream Process development
- Operations Managers
- Manufacturing Science and Technology
- Automation Engineers
- Facilities Manager
- Quality Assurance
- supply chain management